What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to report Anthem, Inc.'s (now Elevance Health) financial results for the quarter ended September 30, 2020, by furnishing a press release that contains these results.

What is the significance of the information not being 'filed' under Section 18?

Information designated as 'furnished' and not 'filed' under Section 18 of the Securities Exchange Act of 1934 means that the company generally cannot be held liable under Section 18 for the information contained within it. It also means the information does not automatically become part of a 'registration statement' under the Securities Act of 1933 unless expressly incorporated.

What are some of the major risks mentioned in the forward-looking statements?

The filing outlines significant risks, including the ongoing impact of public health emergencies like COVID-19, fluctuations in healthcare costs and utilization, changes in federal and state regulations (such as the Affordable Care Act), economic conditions, competitive pressures, potential litigation and government investigations, and risks associated with mergers and acquisitions.

Does this filing provide specific Q3 2020 financial numbers?

This 8-K filing itself does not contain the specific financial numbers. Instead, it refers investors to Exhibit 99.1, which is the press release dated October 28, 2020, where Anthem, Inc. reported its Q3 2020 financial results.

ELV 8-K: Earnings & Results

Summary

Elevance Health, Inc. (operating as Anthem, Inc. at the time) filed an 8-K on October 28, 2020, primarily to report its financial results for the quarter ended September 30, 2020. The filing includes a press release detailing these results, which is furnished as an exhibit. Investors should note that the information provided in this filing, and the attached press release, is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same legal implications as formally filed reports regarding forward-looking statements. The report also includes extensive forward-looking statements and a detailed cautionary note outlining various risks and uncertainties that could materially affect the company's future performance. These risks encompass a wide range of factors, including the impact of public health emergencies like COVID-19, healthcare cost trends, regulatory changes (including the ACA), economic conditions, competitive pressures, and litigation risks, among others. Investors are advised to carefully consider these disclosures when evaluating the company's outlook.

Key Highlights

1Anthem, Inc. (now Elevance Health) reported its financial results for the third quarter of 2020 via an 8-K filing on October 28, 2020.
2The primary purpose of the 8-K was to furnish a press release detailing the Q3 2020 financial performance.
3Information furnished in this 8-K is not considered 'filed' for Section 18 purposes, limiting liability for its contents.
4The filing includes a comprehensive section on forward-looking statements, emphasizing potential risks and uncertainties.
5Key risk factors mentioned include the impact of COVID-19, healthcare cost trends, regulatory environment (ACA), and competitive landscape.
6Other significant risks highlighted involve potential litigation, government investigations, and operational challenges like information system modernization.

Elevance Health, Inc. 8-K Report, Financial Results (Oct 28, 2020)

Summary

Key Highlights

Frequently Asked Questions